Clinical Trial Update: Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of ME-015 (suplatast tosilate) for cough associated with idiopathic pulmonary fibrosis, with status sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• ME-015 (Suplatast Tosilate) (suplatast tosilate)

Snippet

Sponsor: Melius Pharma AB | Conditions: Idiopathic Pulmonary Fibrosis, Cough | Phase 2 | Status: ACTIVE_NOT_RECRUITING